Source: The Business Journals: Raleigh/Durham

Tergus: Durham CDMOs merger backed by private equity

The merged company is an end-to-end CDMO that can support both clinical trial manufacturing and commercial-scale production.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Michael Kane's photo - CEO of Tergus

CEO

Michael Kane

CEO Approval Rating

82/100

Read more